Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model
Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model. // ASPET Discovery. – URL: https://www.sciencedirect.com/science/article/pii/S3050567426000167?dgcid=rss_sd_all
Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model. ASPET Discovery. https://www.sciencedirect.com/science/article/pii/S3050567426000167?dgcid=rss_sd_all
“Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model.” ASPET Discovery.
@article{article29439,
title = {Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model},
journal = {ASPET Discovery},
url = {https://www.sciencedirect.com/science/article/pii/S3050567426000167?dgcid=rss_sd_all}
}